Silver Spring, Maryland–(ENEWSPF)–June 2, 2011. The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications.
In July 2010, the FDA reported that a safety review of ARBswould be performed after a published study found a small increased risk of cancer in patients taking an ARB compared to…
